LPL Financial LLC Purchases 6,123 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH)

LPL Financial LLC grew its stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 21.1% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 35,198 shares of the company's stock after buying an additional 6,123 shares during the period. LPL Financial LLC owned approximately 0.07% of Prestige Consumer Healthcare worth $2,749,000 as of its most recent filing with the SEC.

Several other hedge funds have also made changes to their positions in PBH. Kestra Investment Management LLC acquired a new position in Prestige Consumer Healthcare in the 4th quarter valued at approximately $27,000. GAMMA Investing LLC raised its stake in shares of Prestige Consumer Healthcare by 18.9% in the fourth quarter. GAMMA Investing LLC now owns 1,383 shares of the company's stock valued at $108,000 after purchasing an additional 220 shares in the last quarter. Blue Trust Inc. lifted its position in Prestige Consumer Healthcare by 24.8% in the fourth quarter. Blue Trust Inc. now owns 2,190 shares of the company's stock worth $158,000 after purchasing an additional 435 shares during the period. KBC Group NV lifted its position in Prestige Consumer Healthcare by 28.3% in the fourth quarter. KBC Group NV now owns 2,048 shares of the company's stock worth $160,000 after purchasing an additional 452 shares during the period. Finally, Longboard Asset Management LP acquired a new stake in Prestige Consumer Healthcare during the fourth quarter worth $201,000. Institutional investors own 99.95% of the company's stock.

Insiders Place Their Bets

In other Prestige Consumer Healthcare news, SVP Mary Beth Fritz sold 1,678 shares of the business's stock in a transaction dated Monday, March 10th. The stock was sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares of the company's stock, valued at approximately $1,544,130. The trade was a 8.91 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 1.60% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

Several analysts have recently weighed in on PBH shares. Canaccord Genuity Group lifted their target price on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Oppenheimer lifted their price objective on Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an "outperform" rating in a report on Thursday, February 13th. Royal Bank of Canada upped their price objective on Prestige Consumer Healthcare from $96.00 to $97.00 and gave the company a "sector perform" rating in a research note on Friday, March 21st. StockNews.com downgraded Prestige Consumer Healthcare from a "buy" rating to a "hold" rating in a research report on Tuesday, April 8th. Finally, DA Davidson upped their price target on Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a "buy" rating in a research report on Friday, February 7th. Four investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $93.33.

Prestige Consumer Healthcare Price Performance

Shares of Prestige Consumer Healthcare stock traded down $1.22 during trading on Tuesday, reaching $80.90. The company's stock had a trading volume of 333,826 shares, compared to its average volume of 284,793. The stock has a 50-day moving average price of $84.69 and a two-hundred day moving average price of $79.97. The stock has a market capitalization of $4.01 billion, a P/E ratio of 18.95, a price-to-earnings-growth ratio of 2.69 and a beta of 0.47. The company has a current ratio of 3.68, a quick ratio of 2.20 and a debt-to-equity ratio of 0.56. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, topping analysts' consensus estimates of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. As a group, sell-side analysts anticipate that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.